Advertisement

Ads Placeholder
Loading...

Epigenomics AG

EPGNF•PNK
Healthcare
Medical - Diagnostics & Research
$1.12
$0.00(0.00%)
U.S. Market opens in 57h 53m

Epigenomics AG (EPGNF) Stock Overview

Explore Epigenomics AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap982.2K
P/E Ratio-2.84
EPS (TTM)$-3.69
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$1.13
3 Months$1.14
1 Year Target$1.24

EPGNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Epigenomics AG (EPGNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.84 and a market capitalization of 982.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
41.77%
3-Year Change
57.75%
5-Year Change
-59.57%
All-Time (Max) Change
-87.34%

Contact Information

https://www.epigenomics.com
49 30 243 450
Geneststrasse 5, Heidelberg, NaN, 10829

Company Facts

60 Employees
IPO DateDec 31, 2010
CountryDE
Actively Trading

Frequently Asked Questions